0,954  0,003  Respiratory analeptic
0,915  0,003  Analeptic
0,907  0,003  Psychostimulant
0,671  0,003  Cholinergic antagonist
0,669  0,003  Acetylcholine antagonist
0,644  0,001  Vesicle monoamine transporter inhibitor
0,616  0,003  Dopamine uptake inhibitor
0,610  0,014  Cognition disorders treatment
0,599  0,005  Transplant rejection treatment
0,593  0,003  Acetylcholine nicotinic antagonist
0,577  0,009  Hypoxia-inducible factor 1 alpha inhibitor
0,574  0,008  CYP2D6 inhibitor
0,551  0,009  Dependence treatment
0,540  0,004  Antismoking
0,533  0,017  Calcium channel L-type activator
0,517  0,004  5 Hydroxytryptamine uptake inhibitor
0,514  0,004  Acetylcholine M1 receptor antagonist
0,567  0,063  Antiinflammatory
0,499  0,002  Nicotinic alpha4beta2 receptor antagonist
0,498  0,023  Spasmolytic
0,476  0,004  Neuronal nicotinic receptor antagonist
0,461  0,018  Cardiodepressant
0,441  0,004  Acetylcholine muscarinic antagonist
0,489  0,052  Analgesic
0,432  0,036  FMO1 substrate
0,399  0,003  Nicotinic receptor alpha3 subunit antagonist
0,437  0,044  Stroke treatment
0,430  0,037  CYP2D6 substrate
0,377  0,003  Nicotinic receptor alpha7 subunit antagonist
0,404  0,045  Antidepressant
0,336  0,003  Nicotinic receptor alpha4 subunit antagonist
0,373  0,059  Mood disorders treatment
0,339  0,029  5 Hydroxytryptamine uptake stimulant
0,320  0,017  Attention deficit/hyperactivity disorder treatment
0,339  0,042  Cardiotonic
0,322  0,032  Antiarrhythmic
0,331  0,045  Renal disease treatment
0,326  0,041  Flavin-containing monooxygenase substrate
0,296  0,018  Antiparkinsonian, tremor relieving
0,317  0,044  Hypolipemic
0,300  0,030  Antihypotensive
0,324  0,056  Antihypercholesterolemic
0,277  0,011  Bronchodilator
0,312  0,048  Cardiovascular analeptic
0,277  0,015  Anesthetic local
0,316  0,062  CYP1A2 substrate
0,249  0,003  Nicotinic receptor beta4 subunit antagonist
0,257  0,017  Cocaine dependence treatment
0,306  0,069  Interleukin 2 agonist
0,259  0,027  Anesthetic
0,256  0,027  Hair growth stimulant
0,267  0,040  Peptidyltransferase inhibitor
0,269  0,046  Antiparkinsonian, rigidity relieving
0,303  0,081  Immunomodulator
0,250  0,029  Skeletal muscle relaxant
0,331  0,114  Antibacterial
0,220  0,010  HDL-cholesterol increasing
0,303  0,095  Vasodilator, peripheral
0,263  0,056  Tyrosine 3 hydroxylase inhibitor
0,287  0,081  NOS3 expression inhibitor
0,253  0,047  Abortion inducer
0,221  0,020  Antirickettsial
0,243  0,046  Non-steroidal antiinflammatory agent
0,267  0,078  UGT2B4 substrate
0,222  0,033  CNS active muscle relaxant
0,253  0,065  Potassium channel blocker
0,306  0,120  CYP2C19 inhibitor
0,195  0,011  Sphingomyelinase inhibitor
0,206  0,033  UGT2B10 substrate
0,220  0,048  Muscle relaxant
0,181  0,009  Sigma receptor antagonist
0,173  0,007  NMDA 2B receptor antagonist
0,239  0,074  Antiglaucomic
0,303  0,139  Antiparkinsonian
0,277  0,113  CYP3A4 substrate
0,191  0,028  Antitussive
0,166  0,005  Dopamine transporter inhibitor
0,206  0,050  Urinary incontinence treatment
0,248  0,094  Radioprotector
0,291  0,137  TNF expression inhibitor
0,218  0,065  Anesthetic general
0,187  0,036  SULT1A3 substrate
0,243  0,097  CYP2C19 substrate
0,279  0,136  Antipruritic, allergic
0,209  0,068  Sedative
0,187  0,046  UGT2B9 substrate
0,219  0,079  Antiviral (West Nile virus)
0,205  0,070  Pneumotoxic
0,136  0,005  Sigma 1 receptor antagonist
0,216  0,085  Potassium channel (Voltage-sensitive) blocker
0,162  0,033  Growth stimulant
0,296  0,169  5 Hydroxytryptamine release inhibitor
0,183  0,058  Toxic, respiratory center
0,207  0,086  HERG channel blocker
0,257  0,136  GST A substrate
0,142  0,025  Electron transport complex I inhibitor
0,164  0,052  Cell wall synthesis inhibitor
0,224  0,113  Gastrin inhibitor
0,151  0,041  Ca2+-transporting ATPase inhibitor
0,177  0,071  UGT2B7 substrate
0,134  0,029  Acetylcholine release stimulant
0,158  0,053  Neurotrophic factor
0,239  0,135  Antithrombotic
0,128  0,024  Acetylcholine nicotinic agonist
0,165  0,062  Carcinogenic, group 1
0,108  0,005  Alpha-mannosidase inhibitor
0,220  0,117  Radiosensitizer
0,134  0,032  HIV-1 integrase (Overall Integration) inhibitor
0,118  0,017  Acetylcholine M2 receptor antagonist
0,113  0,015  Acetylcholine M3 receptor antagonist
0,250  0,155  Histamine release inhibitor
0,208  0,113  Interleukin agonist
0,147  0,053  Glutamate receptor antagonist
0,226  0,136  CTGF expression inhibitor
0,115  0,024  Hematopoietic
0,183  0,092  Insulin sensitizer
0,208  0,118  UGT1A9 substrate
0,134  0,045  Excitatory amino acid transporter EAAC1 inhibitor
0,108  0,019  Narcotic antagonist
0,236  0,148  Vasodilator, coronary
0,095  0,006  Mannosidase inhibitor
0,159  0,072  Eye irritation, high
0,193  0,107  NOS2 expression inhibitor
0,172  0,087  Sleep disorders treatment
0,207  0,123  5 Hydroxytryptamine 1E antagonist
0,108  0,025  Glutamate decarboxylase inhibitor
0,152  0,069  Antidiarrheal
0,128  0,047  Mucolytic
0,150  0,069  UGT2B15 substrate
0,117  0,037  UGT2B11 substrate
0,114  0,035  Paget's disease treatment
0,238  0,159  Immunosuppressant
0,168  0,091  Sensitization
0,112  0,035  Antispirochetal
0,126  0,050  Ferrochelatase inhibitor
0,186  0,113  Urologic disorders treatment
0,220  0,148  Cholesterol antagonist
0,124  0,053  Endometrios treatment
0,114  0,043  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,220  0,149  Antihypertensive
0,152  0,083  Uterine stimulant
0,213  0,145  FMO3 substrate
0,104  0,035  Tocolytic
0,122  0,055  SULT1A1 substrate
0,186  0,121  Acute neurologic disorders treatment
0,077  0,012  NMDA receptor subunit 3A antagonist
0,173  0,109  VEGF expression inhibitor
0,084  0,022  Acetylcholine M5 receptor antagonist
0,195  0,134  Amyotrophic lateral sclerosis treatment
0,076  0,015  Nicotinic alpha3beta2 receptor antagonist
0,189  0,130  Superoxide dismutase inhibitor
0,227  0,171  CYP2C9 substrate
0,081  0,026  Prostaglandin EP2 antagonist
0,161  0,107  UGT1A1 substrate
0,118  0,064  Transcription factor STAT6 inhibitor
0,137  0,083  Genotoxic
0,099  0,047  Acetylcholine agonist
0,186  0,134  Lipoprotein disorders treatment
0,099  0,048  NMDA receptor antagonist
0,078  0,028  Uterine relaxant
0,084  0,038  Dopamine D2 antagonist
0,084  0,038  Antidote, organophosphates
0,050  0,007  Ceramide glucosyltransferase inhibitor
0,182  0,139  5 Hydroxytryptamine release stimulant
0,093  0,050  Antiviral (Hepatitis A)
0,206  0,165  CYP3A4 inhibitor
0,104  0,064  Expectorant
0,070  0,031  Antimycoplasmal
0,142  0,104  Antipruritic
0,071  0,033  NMDA 2C receptor antagonist
0,100  0,062  Anabolic
0,077  0,040  Phenylalanine 4-hydroxylase inhibitor
0,099  0,064  Antiemetic
0,116  0,081  Alpha-N-acetylglucosaminidase inhibitor
0,124  0,089  Protein kinase stimulant
0,069  0,035  Adrenaline uptake inhibitor
0,132  0,098  Adenylate cyclase stimulant
0,080  0,047  Dopamine antagonist
0,075  0,042  Opioid mu receptor antagonist
0,102  0,070  GST T1-1 substrate
0,185  0,153  Chemoprotective
0,208  0,177  GST M1-1 substrate
0,042  0,011  Prostaglandin D2 agonist
0,053  0,023  Dopamine D5 antagonist
0,184  0,155  Antiepileptic
0,095  0,067  UDP-glucose 4-epimerase inhibitor
0,088  0,059  Opioid antagonist
0,080  0,051  Somatostatin 1 agonist
0,068  0,042  Antihemophilic
0,075  0,049  CDC25A inhibitor
0,103  0,079  5 Hydroxytryptamine 2B antagonist
0,048  0,026  NMDA receptor subunit 3B antagonist
0,053  0,031  Potassium channel (Inward rectifier) blocker
0,219  0,198  Atherosclerosis treatment
0,097  0,077  Choleretic
0,261  0,240  Caspase 9 stimulant
0,142  0,121  UDP-glucuronosyltransferase substrate
0,031  0,012  Prostaglandin EP2 agonist
0,088  0,070  Antiviral (Rhinovirus)
0,035  0,017  Prostaglandin agonist
0,080  0,063  Carcinogenic, group 2A
0,031  0,013  1,3-Beta-glucan synthase inhibitor
0,133  0,117  Movement disorders treatment
0,032  0,016  Potassium channel (Inward rectifier) 1 blocker
0,070  0,056  Antibiotic
0,067  0,053  Anticholelithogenic
0,169  0,156  Nitric-oxide synthase stimulant
0,031  0,018  Leukotriene B4 receptor 1 antagonist
0,113  0,100  Antianorexic
0,036  0,023  Glutamate (mGluR group II) agonist
0,107  0,095  Contraceptive female
0,023  0,011  Vesicular acetylcholine transporter inhibitor
0,034  0,023  Sodium-dependent vitamin C transporter 2 inhibitor
0,160  0,150  VCAM1 expression inhibitor
0,116  0,107  Sphingosine 1-phosphate receptor 2 antagonist
0,129  0,119  Prostate disorders treatment
0,024  0,015  Prostaglandin E2 agonist
0,032  0,023  Glutamate (mGluR2) agonist
0,088  0,080  Sulfotransferase substrate
0,031  0,023  Cholesterol ester transfer protein antagonist
0,147  0,142  Neurotrophic factor enhancer
0,163  0,158  Hypoglycemic
0,041  0,038  Heme oxygenase inhibitor
0,064  0,062  SULT2A1 substrate
0,023  0,022  Sigma 2 receptor antagonist
0,064  0,063  Aminopeptidase I inhibitor

